Category Archives: Epigenetics

Exposure to environmental pollution, such as diesel exhaust or concentrated urban air particles, during pregnancy could increase a childs risk of developing asthma via epigenetic mechanisms. Recent research in the Journal of Physiology Lung Cellular and Molecular Physiology suggests that this allergic susceptibility might even be epigenetically passed down for several generations.

Asthma forms as a result of the complex interaction between someones genes, epigenetic marks, and the environment. Epigenetics, the study of how chemical tags impact the expression of genes, is coming more into focus as researchers attempt to understand this widespread respiratory condition and its origins.

Previous research has uncovered an association betweeninhaling diesel exhaust fumes and notable epigenetic changes which can affect around 400 genes. Other studies link birth season and allergy risk and uncover new gene targets for creating drugs to combat allergic diseases and reduce allergic responses.

In this study, researchers from Harvard T.H. Chan School of Public Health, along with Bringham and Womens Hospital, expanded on their prior observations that maternal particle or allergen exposure can be connected to increased asthma onset risk in the immediate progeny, known as the F1 generation. Interestingly, their new research supports the notion that it actually extends all the way to the third generation (F3), even though the effect is not as strong.

Using a mouse model, they found that pregnant mothers exposed to pollutants increased the risk of asthma in their children, grandchildren, and great-grandchildren. The scientists assessed key immune cells known as dendritic cells from within the mices lungs, since these special cells are thought to be critical in early-life onset of asthma and maternal transmission of asthma risk.

All three generations of offspring exposed to diesel exhaust had an abnormal boost in dendritic cells, used as a common marker for allergy. Descendants of pollutant-exposed mothers also had increased levels of interleukin proteins that are linked to immune system regulation.

They assessed the pattern of DNA methylation, a common epigenetic mechanism defined as the addition of a methyl mark which often suppresses the expression of genes, in dendritic cells of each generation. After purifying the dendritic cells and isolating the DNA, the researchers used enhanced reduced representation bisulfite sequencing (eRRBS).

Our methylome analysis suggests that the transmission is associated with aberrant DNA methylation, the team reported. Increased asthma susceptibility after a single maternal exposure to [diesel exhaust particles] or [concentrated urban air particles] transmits risk to F1, F2, and, to a lesser extent, F3 generations. This was associated with altered methylation of promoters of genes associated with lung development, IL-4 signaling, and chromatin dynamics.

Transgenerational epigenetic inheritance is a highly debated topic that certainly requires more research. An effect must be observed in generations that were not exposed to the triggering stimulus in this case, pollution in order to qualify as transgenerational. Recent research has suggested that mothers exposed to lead may influence DNA methylation patterns of her children and grandchildren. Other studies, however, show that nutrition memory does not epigenetically persist to great grandchildren.

To further substantiate the epigenetic effect the group observed, the researchers treated a subset of immediate offspring with a DNMT inhibitor, which inhibits the epigenetic enzyme that catalyzes DNA methylation. This drug can modify DNA methylation in the epigenome and could potentially reduce the transmission of asthma susceptibility. Indeed, they found that injecting the F1 generation with a DNMT inhibitor called decitabine for three days immediately before mating was able to attenuate the asthma risk in grandchildren and great-grandchildren.

Expanding our knowledge of epigenetic origins of asthma may lead to novel prevention and treatment strategies. Not only is asthma an inflammatory disease but it is an epigenetic disease as well, explained corresponding researcher Alexey Fedulov. According to him, This approach may allow entirely new therapeutic strategies.

Source: Gregory, D.J. et al. (2017). Transgenerational transmission of asthma risk after exposure to environmental particles during pregnancy. American Journal of Physiology Lung Cellular and Molecular Physiology, 313(2): L395-L405.

Reference: The American Physiological Society. Environmental Pollution Exposure during Pregnancy Increases Asthma Risk for Three Generations. The American Physiological Society Press Release. 17 May 2017. Web.

Read the original:
Pregnant Moms' Exposure to Pollution May Epigenetically Increase Child's Asthma Susceptibility - WhatIsEpigenetics.com

That our lifestyle and environment affect our health is not new, but you might not be aware that it can also affect our genetic makeup.

An upcoming talk by Andrew Abrams and hosted by Biotech Without Borders at Genspace, the Downtown Brooklyn community bio lab, will explore the topic of epigenetics, the changes in our genome or gene expression that come with changes in our environment.

There are many profound biological questions that genetics is unable to resolve, not least among them some of our most intimate concerns about human health and disease, and the critical role of our lifestyle and other environmental factors in shaping these, according to the events page. The exploding field of epigenetics has the potential to address these questions. In this talk we will explore what we mean by epigenetics, why it is so important, and how we might be able to harness it for a healthier future.

Tickets are free and open to the public. The talk will be in two weeks, on Wednesday, Sept. 6, at 7 p.m.

See the original post:
Cool talk alert: Epigenetics and what genes can't tell us - Technical.ly Brooklyn

In brief

Epigenetics has always been all the weird and wonderful things that cant be explained by genetics.Denise Barlow (Vienna, Austria)

DNA is just a tape carrying information, and a tape is no good without a player. Epigenetics is about the tape player.Bryan Turner (Birmingham, UK)

I would take a picture of a computer and say that the hard disk is like DNA, and then the programmes are like the epigenome. You can access certain information from the hard disk using the programmes on the computer. But there are certain password protected areas and those which are open. I would say were trying to understand why there are passwords for certain regions and why other regions are open.Jrn Walter (Saarland, Germany)

There is around 2m of DNA in a nucleus of only a few micrometers. We are trying to learn about the mechanisms whereby the DNA gets accessed given the tiny volume of the nucleus.Gunter Reuter (Halle, Germany)

Information management in the nucleus means that some of the genetic information is very very tightly packaged in the genome. Then there is genetic information that has to be on and active all the time, house-keeping genes for example. So epigenetics is a bit like information management at home, something that you need all the time you will not store away, but your old school records you keep packed in boxes in the attic.Peter Becker (Munich, Germany)

The difference between genetics and epigenetics can probably be compared to the difference between writing and reading a book. Once a book is written, the text (the genes or DNA: stored information) will be the same in all the copies distributed to the interested audience. However, each individual reader of a given book may interpret the story slightly differently, with varying emotions and projections as they continue to unfold the chapters. In a very similar manner, epigenetics would allow different interpretations of a fixed template (the book or genetic code) and result in different read-outs, dependent upon the variable conditions under which this template is interrogated.Thomas Jenuwein (Vienna, Austria)

Read more here:
Epigenetics? - What is Epigenetics? - Epigenome NOE

Hello and happy Saturday! Here's our summer roundup of eclectic and under-the-radar health and medical science news.

If you haven't subscribed yet, you can do that by clickinghere.

Scientists now know that the mere act of living leaves molecular scars on our genes.

But it was long assumed that those marks were wiped clean when the genes were passed on to the next generation.

Not so, according to research in the mysterious field of epigenetics. And a new paper shows some of the first evidence of how offspring are affected.

"It was assumed there was zero transmission of epigenetic information from one generation to another, McGill University pharmacology professor Moshe Szyf told us. "This paper adds to that body of evidence showing that assumption is not true."

Epigenetics is an emerging field of research proving once again that DNA is complicated. It won't work without a second layer of genetic activity called epigenetics, a series of biochemical processes that translate DNA's genetic information into cellular mechanisms in the human body.

And the way those epigenetic programs turn certain genes up or down, on or off can be affected by what we eat, and how we live, how much stress we experience, or what toxic exposures we have.

"The big question is how much the experiences we are going through, including trauma, diseaseor famine, etc.is passed to the next generation," said Szyf.

The studypublishedin Science shows evidence that fruit fly offspring inherit a specific epigenetic change critical to the embryo's development. But what do humans have in common with fruit flies? A lot.

"Evolution has taught us that principles that work in one organism usually work in many organisms. And if a basic process appears in a fruit fly, it usually also appears in humans," Szyf said.

The first clues to epigenetic heritability came from curiousobservationsfollowing a series of famine cycles in a northern province of Sweden in the early 1800s. Scientists linked changes in life expectancy to grandparents' exposure to feast or famine.

Otherobservationsmade after the Dutch famine during the Second World Warshowed persistent changes in DNA expression six decades later, adding to evidence that life experiences can leave permanent marks on our genes.

"We were under the illusion that if we know genetics we understand everything about life," Szyf said. "Epigenetic information is much more dynamic and responsive to the environment. And it raises the possibility that experience can be passed from one generation to the next. And that's the allure of this whole thing."

The irony of peer review is that the process itself is never peer reviewed. (Shutterstock)

Imagine having all of your colleagues and all of your competitors looking over your shoulder at everything you do. And now imagine them pointing out everything you did wrong and sending you back to do it all over again.

That's the basic premise of scientific peer review. Before a research paper is published in a scientific journal, several scientists examine the work to determine if the methods are sound and the conclusions are supported by the data. It's a much-heralded pillar of the scientific process.

But the irony of peer review is that the process itself is never peer reviewed. David Moher, a senior scientist at the Ottawa Hospital Research Institute, called for the "black box" of peer review to be opened, in a commentary he co-authored inScience.

"We have very little evidence that peer review works," Moher told us, pointing to the riseof predatory journals as evidence of the urgent need to improve peer review.

Predatory journals disguise themselves as legitimate scientific publications andmake money by charging scientists for publishing their papers. There isevidenceof these journals accepting scientificgibberishandappointingpeople who don't even exist to their editorial boards.(Readabout Dr. Fraud in our March 26 newsletter.)

"If journals do not get a handle on peer review, then they can't distinguish themselves from these predatory journals," Moher said.

Ivan Oransky and Adam Marcus arewatchdogswho track retractions of scientific papers on their blog Retraction Watch. Theycomparedthe current system of peer review to a toothless guard dog, incapable of spotting fraud or plagiarism, or keeping bad science from polluting the scientific record.

"There's a tremendous movement to open science," Moher said, calling on publishers to open their doors and allow scientists to study their peer review process. "I don't want to trash journals. I want to make them better."

As part of our summer Second Opinion series, we're featuring great Canadian moments in medical history. This week meetCharles BeerandRobert Noble.

Robert Noble and Charles Beer discovered a treatment for leukemia almost 60 years ago. (Canadian Medical Hall of Fame)

Together they discovered a chemotherapy drug in a Jamaican periwinkle plant that arrived in the mail.

It was an accidental discovery. They weren't looking for anti-cancer agents. Instead, the two researchers at the University of Western Ontario (now Western University) were searching for diabetes drugs. And they were curious what magic might be found in the periwinkle sample that had been mailed to Noble's brother.

"The disease of cancer was certainly far from our thoughts when we learned of a tea made from the leaves of a West Indian shrub that was supposedly useful in the control of diabetes mellitus," they wrote in their 1958 paper "Role of Chance Observations in Chemotherapy: Vinca Rosea."

Beer was an expert chemist, and he knew how to extract the plant's key compound. But whenthose extracts were fed to diabetic rabbits nothing happened. The blood sugar levels didn't change. But when they injected the extract into the rabbits' veins, the animals quickly died from a bacterial infection. "Apparently some natural barrier to infection was being depressed," they wrote.

They soon realized the periwinkle compound lowered the levels of white blood cells and depressed bone marrow. Could this be a possible treatment for leukemia, caused when white blood cells proliferate out of control?

They started growing the plant nearby so they could have a steady supply of the extract, even though in the Canadian climate the plants expressed much less of the active ingredient. Once they could reliably extract the compound they tested it on cancer patients at Princess Margaret Hospital in Toronto. That was almost 60 years ago.

Today vinblastine is on the World Health Organization'slistof essential medicines, used in combination with other drugs on lymphoma and other cancers.

Beerdiedin 2010 at age 95. Noble died in 1990 at age 80.

These fascinating stories of discovery were selected from the Canadian Medical Hall of Fame, a medical history organization that began in 1994. Every year, six Canadians are inducted. There is a small exhibit hall in London, Ont., but executive director Lissa Foster told us the real hall livesonline, with video features for the 125 laureates.

Thanks for reading! You canemail usany time with your thoughts or ideas. And if you like what you read, consider forwarding this to a friend.

Go here to see the original:
SECOND OPINION | Your life is leaving genetic scars that might show up in your child's genes - CBC.ca

Co-exclusive global licence covers manufacture and integration of CEGX TrueMethyl technology for oxidative bisulfite sequencing (oxBS-Seq) with Targeted Methylation and NuGEN Ovation Methyl-Seq systems.

Cambridge Epigenetix (CEGX) and NuGEN Technologies, leaders in innovative epigenetic technologies, have announced that they have entered into a partnership agreement to integrate the CEGX TrueMethyl technology for oxidative bisulfite sequencing (oxBS-Seq) with NuGENs innovative NGS library preparation kits. The signing of the agreement will enable CEGX to focus on its epigenetic biomarker discovery programmes, both in-house and in partnership with leading biopharma companies, and will further strengthen NuGENs epigenetics portfolio of whole genome Methyl-Seq, Reduced Representation Bisulfite Sequencing (RRBS), and patented SPET target enrichment systems.

The epigenetic DNA modifications 5-hydroxymethylcytosine (5hmC) and 5-methylcytosine (5mC) play very different roles in gene regulation. Cambridge Epigenetix enhanced the appreciation of 5hmC through the introduction of its TrueMethyl oxBS-Seq system. Their developments have enabled researchers to further elucidate the role of DNA methylation in disease occurrence and progression, highlighting the potential for such epigenetic marks in the development of improved diagnostic and prognostic assays. The integration of TrueMethyl oxBS and NuGENs patented library preparation technologies will broaden the scope of accessible samples for the detection of these emerging markers.

Jason Mellad, CEO at Cambridge Epigenetix, commented: This partnership will enable both CEGX and NuGEN to leverage our strengths to facilitate advances in the epigenetics field. CEGX is committed to realising the promise of epigenetics through the development of improved, minimally invasive diagnostic and prognostic tests for accurate and early detection of a range of diseases, including cancer. We are working with leading biopharma companies as well as progressing our own high-value internal programmes, applying our expertise and advanced proprietary technology for robust biomarker identification, particularly from liquid biopsy samples. NuGENs reach and reputation for delivering high-quality genomics solutions to the market makes them the ideal partner to further develop TrueMethyl technology to deliver a range of new products to enhance epigenetics research.

Nitin Sood, CEO at NuGEN Technologies, said: We are delighted to be working with CEGX to provide the tools to improve the understanding and appreciation of epigenetics in cellular function. The goal of all of our products has always been to maximize the information that our customers obtain from their nucleic acid samples. By combining the TrueMethyl oxBS technology with our NGS library preparation kits, we will provide our customers with whole genome and targeted methylation products to unlock the tremendous potential of epigenetics. The combination provides access to more detailed, higher resolution epigenetic information in an integrated, cost-effective solution. The technology complements our Methyl-Seq and Single Primer Enrichment Technology product lines, and we are delighted to provide researchers with the most comprehensive solution for epigenetics research.

New products resulting from this partnership are anticipated by the end of the year and will be available directly from NuGEN. TrueMethyl products should still be ordered through CEGX until further notice. For more information about TrueMethyl, including how to order, please visit https://www.cambridge-epigenetix.com/products.

Read more from the original source:
Cambridge Epigenetix and NuGEN Technologies Sign Agreement ... - Technology Networks

Our understanding of ADHD has grown by leaps and bounds over the past 30 years. What started as hyperkinetic impulse disorder its primary symptom excessive hyperactivity over time shifted to attention deficit disorder and a focus on problems with inattention, then to reward functioning, and later to executive functioning. None of these translations was wrong, in and of itself;each set of highlighted symptoms is a distinct and important part of the disorder we now call ADHD. But the facets were poorly integrated with one another, and thus painted an incomplete picture of a highly complex condition.

Now, researchers understand that ADHD is primarily a disorder of self-regulation. Self-regulation weaves together all the older theories of ADHD into one cohesive picture; it is also what allows humans to manage impulses, engage or disengage attention, and navigate between deliberate and automatic responses to different situations. The ability to self-regulate is managed across the brain in highly interconnected ways; similar brain nodes regulate both attention and emotion and when one area isnt performing well, the others suffer, too.

The newest theories of ADHD, then, dont focus on a single underperforming area of the brain, as older ones did. Its now understood that ADHD manifests when neurons misfire in the ever-shifting communications and connections between multiple areas of the brain. Emerging research also suggests that these neurological wrinkles may be driven by the environment as much (or more) than they are by genes.

[Quiz: Can You Tell the Difference Between ADHD Myths and ADHD Facts?]

This new framework provides a much more nuanced and complex view of ADHD, but it also provides hope: If ADHD symptoms can be worsened by environmental causes, they can be improved by them, too. Read on to find out how.

Researchers have long known that ADHD can be passed down genetically. But the idea that we can find the single gene responsible for ADHD and fix it is now understood to be outdated. The newest theory of ADHD, as a disorder primarily related to self-regulation, relies on something called epigenetics.

Epigenetics refers to biological traits or changes that cannot be explained by a persons genetic code. Epigenetic mechanisms actually create a physical mark on the DNA when a person undergoes an important experience, whether its positive or negative. These marks which can be added methyl molecules, or a modified histone tail adjust the individuals gene function, changing what the genes do or how strongly they express themselves. In a nutshell, environment and experiences affect a humans development and behavior in an enduring fashion actually altering regions of DNA, with effects that may last for an entire lifetime.

How does it work? It starts with genes the building blocks of who we are and who we become. But beginning at conception, everyone is exposed to different environmental toxins and advantages and after were born, psychological inputs like stress, adversity, and even trauma begin to factor in. Epigenetics takes this input and uses it to change how genes are expressed meaning a genes output isnt fully known until environment and personal history are factored in.

[Free Resource: What to Eat (and Avoid) for Improved ADHD Symptoms]

Epigenetics paints a much more complicated view of ADHD, but also a much more optimistic one; genes do not solely determine an individuals fate. In fact, while genes may make someone more prone to certain diseases or disorders, including ADHD, the entire genetic system is highly dynamic and responsive to input. This means its possible to change the expression of a persons ADHD genes by making certain environmental changes.

Credible and robust epigenetics research confirms these assertions. One experiment1 took two genetically identical mice embryo and, during the prenatal stage, fed their mothers diets that included the toxic element bisphenol-A (BPA). The diet of one mouses mother, however, was supplemented with nutrients like choline, folic acid, and B12; that mouse was later able to avoid the negative effects of the BPA, including obesity and a higher risk of cancer. This phenomenon can be explained by epigenetics the additional nutrients were able to turn off the genes that respond to BPA, and thus protect the mouse from its harmful effects.

Another experiment2 this one involving humans tested whether taking an omega-3 supplement during pregnancy would impact the attention abilities of a mothers child. The study found that children whose mothers had randomly received the supplement had stronger attention at 6 and 12 months, and later had better-developed mental abilities, than did children whose mothers had not taken the supplement. Since this experiment was randomized and the effect was so great, researchers were able to determine a causal effect and again, one that was influenced by epigenetics. Food dyes, artificial preservatives, and lead yielded similar results3 the introduction of each into a childs pre- or post-natal environment had real, causal effects on his or her attention, hyperactivity, and emotional regulation.

Similar experiments have been done on stress and adversity and how exercise can counteract those negative effects. One experiment4 placed rats into a stressful situation for a period of time each day, which resulted in significant epigenetic changes that decreased healthy function. However, when those same rats were also allowed to exercise while still experiencing the stressor the negative effects on the brain were completely eliminated. The study provided a clear example of how exercise can reverse the harmful brain-based effects of a negative early-life experience.

[Daily Exercise Ideas to Boost Focus]

This research suggests that lifestyle changes may help to offset the effects of ADHD genes activated by genetic, chemical, dietary, or other factors. More epigenetic research is needed, however a few things are clear: Omega-3 supplementation, aerobic exercise, and stress management can have real, positive effects on ADHD symptoms in both children and adults.

How big are these effects? Some changes, like reducing the amount of TV a child watches each day, have very small effects on ADHD symptoms only slightly noticeable in a familys everyday life. Others, like increasing omega-3 intake or introducing an exercise regimen, have significantly larger effect sizes up to twice or three times as large as reducing screen time.

Researchers now recommend that anyone with ADHD follows these strategies:

Continuing research is creating an ever-growing body of evidence regarding which lifestyle changes improve ADHD symptoms, and which are less useful. Though findings are still preliminary, the evidence is already strong enough to make them actionable. Simple changes, like exercising more or taking a fish oil supplement, can have real, lasting effects on an individuals ADHD symptoms in other words, genes do not seal your fate.

Learn more in Dr. Niggs book, Getting Ahead of ADHD: What Next-Generation Science Says about Treatments That Work and How You Can Make Them Work for Your Child

1Dolinoy DC, Huang D, Jirtle RL. Maternal Nutrient Supplementation Counteracts Bisphenol A-Induced DNA Hypomethylation in Early Development. PNAS, vol. 104, 2007, pp. 1305613061.2Colombo, John, et al. Maternal DHA and the Development of Attention in Infancy and Toddlerhood. Child Development, vol. 75, no. 4, 2004, pp. 12541267., doi:10.1111/j.1467-8624.2004.00737.x.3 Stevenson, J, et al. The Role of Histamine Degradation Gene Polymorphisms in Moderating the Effects of Food Additives on Childrens ADHD Symptoms. The American Journal of Psychiatry, vol. 167, no. 9, Sept. 2010, pp. 11081115.4 Kashimoto, R.K., et al. Physical Exercise Affects the Epigenetic Programming of Rat Brain and Modulates the Adaptive Response Evoked by Repeated Restraint Stress. Behavioural Brain Research, vol. 296, 2016, pp. 286289., doi:10.1016/j.bbr.2015.08.038.

Read more here:
More Than Just Genes: How Environment, Lifestyle, and Stress Impact ADHD - ADDitude

A certain type of mushroom might epigenetically prevent tumor growth, according to a study published in the Journal of Cancer Research and Treatment. A medicinal mushroom, Phellinus linteus (PL), could come with magical anticancer properties. Researchers from New York Medical College found that histone deacetylase (HDAC) inactivation and histone acetylation led to the death of bladder cancer cells.

Chemotherapy and immunotherapy often come with severe side effects, and for those suffering from bladder cancer, the use of these therapies is limited and often ineffective in the long run. Because of this, a group of scientists sought to find a possible alternative therapy, one that relies on extracts of a very special type of fungus.

According to the researchers, Phellinus linteus has been used in Asian countries for centuries to prevent or treat ailments, including gastroenteric dysfunction, diarrhea, hemorrhage, rheumatoid arthritis, and cancers. In the wild, this mushroom can be found growing on mulberry trees. Interestingly, it is consumed in the form of hot tea in Korean traditional medicine.

Previous articles on What is Epigenetics detail the epigenetic effects and potential cancer-fighting benefits of broccoli, fruits, and other plants. Research has even found that a natural compound in cypress trees could protect against cancer and that green tea might be able to turn genes on or off in women. However, we are still in the beginning stages of understanding and researching these effects and whether they translate to humans in a practical manner.

Now the focus is on mushrooms. The group of researchers aimed to measure the epigenetic effect of this well-known mushroom on the growth of urothelial cell carcinoma(UCC), the most common type of bladder cancer. Those suffering from this particular cancer have limited therapeutic options. Often, the tumor returns, and the side effects brought on by chemotherapy or immunotherapy are a significant drawback.

In one of the first studies assessing the potential benefits of mushrooms against bladder cancer, these researchers found that the growth of human cancer cells was reduced from 60 to 90 percent and that histone deacetylase activity was significantly lost. The results were obtained by examining the effects of three distinct PL extracts on UCC cells in vitro.

HDACs are epigenetic enzymes that remove chemical groups, known as acetyl groups, from histone proteins. DNA wraps around these histones and the expression of our genes is changed depending on how loose or tight the structure is. Read more about chromatin remodeling and the impact it has on gene expression.

Removing an acetyl group will allow the histones to wrap around the DNA more tightly, which will prevent the expression of certain genes. Often times, cancer cells are treated with HDAC inhibitors (HDACi) because HDACs can cause aberrant transcription of key genes that regulate cell functions often linked to cancer, such as cell proliferation, cell-cycle regulation, and apoptosis.

In this study, HDAC activity was reduced as a result of cancerous cells being treated with mushroom extracts and histone acetylation was increased. The researchers used the Epigenase HDAC Activity/Inhibition Direct Assay Kit from EpiGentek to measure HDAC activity. They found that greater than 60% of HDAC activity was reduced after treatment with three distinct extracts or fractions of the mushroom (PL-I, -II, and -III). In addition, both histones H3 and H4 were highly acetylated, which indicated alterations in the chromatin structure.

The present study shows that all three PL-fractions, PL-I, -II, and -III, have anticancer effects on [bladder cancer] cells, although PL-III appears to be the most potent, reported the researchers. Such an anticancer mechanism is attributed to a p21-mediated cell cycle arrest with epigenetic modifications involving HDAC inactivation and hyperacetylation of H3 and H4, ultimately leading to apoptotic cell death.

Overall, the mushroom extracts reduced cell viability through anticancer activity, and histone modifications were thought to induce cell cycle arrest. In light of these results, this mushroom could modify the chromatin structure consisting of histones and DNA ultimately reducing cancer cell viability via a cell cycle arrest. The researchers suggest that DNA methylation, another popular epigenetic mechanism, should be investigated in terms of possible epigenetic effects of these fungus fractions.

This study raises new questions about whether nontraditional medicines could help those suffering from cancer. As we continue to conduct more research and investigate the epigenetic effects of various natural substances on human health and well being, we can begin to understand the potential benefits of alternative medicine and consider developing new therapies in the future.

Source: Bhalodi, A. et al. (2016). Alternative Therapeutic Approach to Urothelial Cell Carcinoma with Medicinal Mushroom Extracts. Journal of Cancer Research and Treatment, 4(5): 73-79.

See original here:
'Magical' Mushroom Could Fight off Cancer with Epigenetics - WhatIsEpigenetics.com

By Dr. Mercola

How much control do you really have over your own life in general, and your health in particular? These questions have puzzled many since the beginning of time. Now, the emerging science of epigenetics is offering some answers that put true control within your reach.

According to some scientists, changing your health may be as "simple" as changing your thoughts and beliefs.

"Contrary to what many people are being led to believe, a lot of emphasis placed on genes determining human behavior is nothing but theory and doctrine," writes Konstantin Erikseni . "We are free to make decisions that impact our lives and those of others. Our beliefs can change our biology. We have the power to heal ourselves, increase our feelings of self-worth and improve our emotional state."

Eriksen goes on to discuss something called "The Central Dogma" of molecular biology, which states that biological information is transferred sequentially and only in one direction (from DNA to RNA to proteins).

The ramification of buying into the central dogma is that it leads to belief in absolute determinism, which leaves you utterly powerless to do anything about the health of your body; it's all driven by your genetic code, which you were born with.

However, scientists have completely shattered this dogma and proven it false. You actually have a tremendous amount of control over how your genetic traits are expressedfrom how you think to what you eat and the environment you live in.

You may recall the Human Genome Projectii , which was launched in 1990 and completed in 2003. The mission was to map out all human genes and their interactions, which would than serve as the basis for curing virtually any disease. Alas, not only did they realize the human body consists of far fewer genes than previously believed, they also discovered that these genes do not operate as previously predicted.

In the featured article, Eriksen describes the experiments of John Cairns, a British molecular biologist who in 1988 produced compelling evidence that our responses to our environment determine the expression of our genes. A radical thought, for sure, but one that has been proven correct on multiple occasions since then.

Eriksen writesiii :

"Cairns took bacteria whose genes did not allow them to produce lactase, the enzyme needed to digest milk sugar, and placed them in petri dishes where the only food present was lactase. Much to his astonishment, within a few days, all of the petri dishes had been colonized by the bacteria and they were eating lactose. The bacterial DNA had changed in response to its environment. This experiment has been replicated many times and they have not found a better explanation than this obvious fact that even primitive organisms can evolve consciously.

So, information flows in both directions, from DNA to proteins and from proteins to DNA, contradicting the "central dogma." Genes can be activated and de-activated by signals from the environment. The consciousness of the cell is inside the cell's membrane. Each and every cell in our bodies has a type of consciousness. Genes change their expression depending on what is happening outside our cells and even outside our bodies."

As if genes changing expression in response to environmental factors such as nutrients wasn't enough, other researchers have demonstrated that this "environment" that your genes respond to also includes your conscious thoughts, emotions, and unconscious beliefs. Cellular biologist Bruce Lipton, PhD., is one of the leading authorities on how emotions can regulate genetic expression, which are explained in-depth in his excellent books The Biology of Belief, and Spontaneous Evolution.

Science has indeed taken us far beyond Newtonian physics, which says you live in a mechanical universe. According to this belief, your body is just a biological machine, so by modifying the parts of the machine, you can modify your health. Also, as a biological machine, your body is thought to respond to physical "things" like the active chemicals in drugs, and by adjusting the drugs that modify your machinery, doctors can modify and control health. However, with the advent of quantum physics, scientists have realized the flaws in Newtonian physics, as quantum physics shows us that the invisible, immaterial realm is actually far more important than the material realm. In fact, your thoughts may shape your environment far more than physical matter!

According to Dr. Lipton, the true secret to life does not lie within your DNA, but rather within the mechanisms of your cell membrane.

Each cell membrane has receptors that pick up various environmental signals, and this mechanism controls the "reading" of the genes inside your cells. Your cells can choose to read or not read the genetic blueprint depending on the signals being received from the environment. So having a "cancer program" in your DNA does not automatically mean you're destined to get cancer. Far from it. This genetic information does not ever have to be expressed...

What this all means is that you are not controlled by your genetic makeup. Instead, your genetic readout (which genes are turned "on" and which are turned "off") is primarily determined by your thoughts, attitudes, and perceptions!

The major problem with believing the myth that your genes control your life is that you become a victim of your heredity. Since you can't change your genes, it essentially means that your life is predetermined, and therefore you have very little control over your health. With any luck, modern medicine will find the gene responsible and be able to alter it, or devise some other form of drug to modify your body's chemistry, but aside from that, you're out of luck The new science, however, reveals that your perceptions control your biology, and this places you in the driver's seat, because if you can change your perceptions, you can shape and direct your own genetic readout.

This new science also reveals that you are in fact an extension of your environment, which includes everything from your thoughts and belief systems, to toxic exposures and exposure to sunlight, exercise, and, of course, everything you choose to put onto and into your body. As Dr. Lipton is fond of saying, the new biology moves you out of victimhood and into Masterymastery over your own health.

It is a supreme confirmation of my favorite saying, "You Can Take Control of Your Health."

Two years ago, a study performed by the Linus Pauling Institute at Oregon State University was showcased at the annual Experimental Biology convention. The study demonstrated how "histone modifications" can impact the expression of many degenerative diseases, ranging from cancer and heart disease to biopolar disorder and even aging itself. According to Rod Dashwood, a professor of environmental and molecular toxicology and head of LPI's Cancer Chemoprotection Program, as quoted in a press releaseiv:

"We believe that many diseases that have aberrant gene expression at their root can be linked to how DNA is packaged, and the actions of enzymes such as histone deacetylases, or HDACs. As recently as 10 years ago we knew almost nothing about HDAC dysregulation in cancer or other diseases, but it's now one of the most promising areas of health-related research."

In a nutshell, we all have tumor suppressor genes, and these genes are capable of stopping cancer cells in their tracks. These genes are present in every cell in your body, but so are proteins called "histones." As Dr. Jean-Pierre Issa at the M.D. Anderson Cancer Center explainsv , histones can "hug" DNA so tightly that it becomes "hidden from view for the cell." If a tumor suppressor gene is hidden, it cannot be utilized, and in this way too much histone will "turn off" these cancer suppressors, and allow cancer cells to proliferate.

Now here's where epigenetics comes in certain foods, such as broccoli and other cruciferous vegetables, garlic, and onions contain substances that act as histone inhibitors, which essentially block the histone, allowing your tumor suppressor genes to activate and fight cancer. By regularly consuming these foods, you are naturally supporting your body's ability to fight tumors.

Certain alternative oncologists also tap directly into the epigenetic mechanism, such as Dr. Nicholas Gonzalez, who uses a three-pronged approach to cancer based primarily on nutrition and detoxification, and Dr. Stanislaw Burzynski, who treats cancer with a gene-targeted approach. His treatment uses non-toxic peptides and amino acids, known as antineoplastons, which act as genetic switches that turn your tumor suppressor genes "on."

So the good news is that you are in control of your genes You can alter them on a regular basis, depending on the foods you eat, the air you breathe, and the thoughts you think. It's your environment and lifestyle that dictates your tendency to express disease, and this new realization is set to make major waves in the future of disease prevention -- including one day educating people on how to fight disease at the epigenetic level. When a disease occurs, the solution, according to epigenetic therapy, is simply to "remind" your affected cells (change its environmental instructions) of its healthy function, so theycan go back to beingnormal cells instead of diseased cells.

You can begin to do this on your own, long before you manifest a disease. By leading a healthy lifestyle, with high quality nutrition, exercise, limited exposure to toxins, and a positive mental attitude, you encourage your genes to express positive, disease-fighting behaviors.

This is what preventive medicine is all about. It's not about taking any one particular nutrient as a supplement to fix one specific "part" of your biological machinery... The more people become willing to embrace this simple truth, the healthier everyone will get.

It's also worth pointing out that epigenetic effects begin before birth.

Epigenetic research from 2009 showed that rat fetuses receiving poor nutrition in the womb become genetically primed for a nutrition-poor environment. As a result of this genetic adaptation, the rats tended to be smaller. They were also at higher risk for a host of health problems throughout their lives, such as diabetes, growth retardation, cardiovascular disease, obesity, and neurodevelopmental delays. Again, while some are tempted to blame such "predispositions" on bad genes, the KEY factor is nutrition, i.e. the cellular environment.

If you're ready to address your dietary choices, read through my comprehensive nutrition plan, which will give you tips and tools for eating healthy, dealing with stress, and living a lifestyle that will support your epigenetic health.

You can also turn your genes off and on with your emotions too. Many, if not most people carry emotional scars; traumas that can adversely affect health. Using techniques like energy psychology, you can go in and correct the trauma and help regulate your genetic expression. My favorite technique for this is the Emotional Freedom Technique (EFT), but there are many others. Choose whichever one appeals to you, and if you don't sense any benefits, try another, until you find what works best for you.

Please, remember that 'You CAN Take Control of Your Health.'

References:

See the article here:
Epigenetics: How Your Mind Can Reprogram Your Genes

In simplified terms, epigenetics is the study of biological mechanisms that will switch genes on and off. What does that mean? Well, if you are new to this whole thing, we first need a quick crash course in biochemistry and genetics:

Now that you understand genetics, lets learn about epigenetics. Epigenetics, essentially, affects how genes are read by cells, and subsequently how they produce proteins. Here are a few important points about epigenetics:

Heres an analogy that might further help you to understand epigenetics. Think of the human life span as a very long movie. The cells would be the actors and actresses, essential units that make up the movie. DNA, in turn, would be the script instructions for all the participants of the movie to perform their roles. Subsequently, the DNA sequence would be the words on the script, and certain blocks of these words that instruct key actions or events to take place would be the genes. The concept of genetics would be like screenwriting. Follow the analogy so far? Good. The concept ofepigenetics, then, would be like directing. The script can be the same, but the director can choose to eliminate certain scenes or dialogue, altering the movie for better or worse. After all, Steven Spielbergs finished product would be drastically different than Woody Allens forthe same movie script, wouldnt it?

* Editors Note: Be wary of self-help claims that exploit epigenetics and seem too good to be true. We recommend you read about the abuseof epigenetics and pseudoscience.

Ready to learn epigenetics in further detail? Read on:Fundamentals of Epigenetics

Read more here:
A Super Brief and Basic Explanation of Epigenetics for ...

Sessions & Tracks

Track 1 : Cancer

Canceris an abnormal growth of cells which have a tendency to multiply in an uncontrolled way. They have a property to metastasize. The branch of medicine that deals with the prevention, diagnosis and treatment of Cancer is called Oncology.

RelatedOncology Conferences|Cancer Conferences|Cancer meetings

16th Global AnnualOncologistsMeeting, April 24-25, 2017 Dubai, UAE; Global Summit onOncology & Cancer, May 25-27, 2017 Osaka, Japan,; InternationalConference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE;9th InternationalCancer Biomarkers Conference, August 07-09, 2017 Osaka, Japan; 15th WorldCongress on Cancer Therapy(977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research andBiomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; InternationalConference on Epigenetics2017, November 13-15, 2017 Frankfurt, Germany; 19thWorld Cancer Conference, Nov 21-23, 2017 London, UK; 11th InternationalConference on Leukemiaand Hematologic Oncology December 04-05, 2017 Madrid, Spain; Medical ExpoCongress on Cancer Drugsand Therapeutics, Sep 11-13, 2017 Paris, France; Global Expertsmeeting on OncologyCase Reports Aug 29-31, 2017 London, UK; 2ndCancer Diagnostics Conference& Expo, May 8-10, 2017 Barcelona, Spain; 9th InternationalConference Cancer BiomarkersAugust 23-24, 2017 Birmingham, UK.

Track 2 : Types of Cancer

Cancers are classified and named depending upon the type of cell they originated and have different forms. Some examples are as follows:

RelatedCancer meetings |Oncology Conferences|Cancer Conferences

9th InternationalCancer Biomarkers Conference, August 07-09, 2017 Osaka, Japan; 15th WorldCongress on Cancer Therapy(977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research andBiomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; InternationalConference on Epigenetics2017, November 13-15, 2017 Frankfurt, Germany; 19thWorld Cancer Conference, Nov 21-23, 2017 London, UK; 11th InternationalConference on Leukemiaand Hematologic Oncology December 04-05, 2017 Madrid, Spain; 16th Global AnnualOncologistsMeeting, April 24-25, 2017 Dubai, UAE; Global Summit onOncology & Cancer, May 25-27, 2017 Osaka, Japan,; InternationalConference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE; Medical ExpoCongress on Cancer Drugsand Therapeutics, Sep 11-13, 2017 Paris, France; Global Expertsmeeting on OncologyCase Reports Aug 29-31, 2017 London, UK; 2ndCancer Diagnostics Conference& Expo, May 8-10, 2017 Barcelona, Spain; 9th InternationalConference Cancer BiomarkersAugust 23-24, 2017 Birmingham, UK.

Track 3 : Cancer Genetics

Certain changes to genes can alter and control the functioning of the body cells, their growth and division. This causesCancer.

Cancercausing genetic changes :

RelatedCancer Conferences|Cancer meetings|Oncology Conferences

16th Global AnnualOncologistsMeeting, April 24-25, 2017 Dubai, UAE; Global Summit onOncology & Cancer, May 25-27, 2017 Osaka, Japan,; InternationalConference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE;9th InternationalCancer Biomarkers Conference, August 07-09, 2017 Osaka, Japan; 15th WorldCongress on Cancer Therapy(977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research andBiomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; InternationalConference on Epigenetics2017, November 13-15, 2017 Frankfurt, Germany; 19thWorld Cancer Conference, Nov 21-23, 2017 London, UK; 11th InternationalConference on Leukemiaand Hematologic Oncology December 04-05, 2017 Madrid, Spain; Medical ExpoCongress on Cancer Drugsand Therapeutics, Sep 11-13, 2017 Paris, France; Global Expertsmeeting on OncologyCase Reports Aug 29-31, 2017 London, UK; 2ndCancer Diagnostics Conference& Expo, May 8-10, 2017 Barcelona, Spain; 9th InternationalConference Cancer BiomarkersAugust 23-24, 2017 Birmingham, UK.

Track 4 : Cancer : Diagnostics and Staging

Canceris suspected in a view of a persons symptoms ,screening tests. Affirmation thatCanceris present requires diagnostic tests which is followed by staging. Staging is way of analysing the tumor, its size, location and the treatment depending on theCancerstage.It helps to determine the Prognosis of the patient i,e treatment prediction ,disease outcome and patients recovery chances.

RelatedCancer Conferences|Cancer meetings|Oncology Conferences

9th InternationalCancer Biomarkers Conference, August 07-09, 2017 Osaka, Japan; 15th WorldCongress on Cancer Therapy(977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research andBiomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; InternationalConference on Epigenetics2017, November 13-15, 2017 Frankfurt, Germany; 19thWorld Cancer Conference, Nov 21-23, 2017 London, UK; 11th InternationalConference on Leukemiaand Hematologic Oncology December 04-05, 2017 Madrid, Spain; 16th Global AnnualOncologistsMeeting, April 24-25, 2017 Dubai, UAE; Global Summit onOncology & Cancer, May 25-27, 2017 Osaka, Japan,; InternationalConference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE; Medical ExpoCongress on Cancer Drugsand Therapeutics, Sep 11-13, 2017 Paris, France; Global Expertsmeeting on OncologyCase Reports Aug 29-31, 2017 London, UK; 2ndCancer Diagnostics Conference& Expo, May 8-10, 2017 Barcelona, Spain; 9th InternationalConference Cancer BiomarkersAugust 23-24, 2017 Birmingham, UK.

Track 5 : Cancer: Treatment and Therapy

There are many sorts ofCancertreatment. The treatment varies depending on the type of Cancer and its stage.The following are the main types ofCancertreatment :

Related Oncology Conferences|Cancer Conferences|Cancer meetings

InternationalConference on Epigenetics2017, November 13-15, 2017 Frankfurt, Germany; 19thWorld Cancer Conference, Nov 21-23, 2017 London, UK; 11th InternationalConference on Leukemiaand Hematologic Oncology December 04-05, 2017 Madrid, Spain; Medical ExpoCongress on Cancer Drugsand Therapeutics, Sep 11-13, 2017 Paris, France; Global Expertsmeeting on OncologyCase Reports Aug 29-31, 2017 London, UK; 2ndCancer Diagnostics Conference& Expo, May 8-10, 2017 Barcelona, Spain; 9th InternationalConference Cancer BiomarkersAugust 23-24, 2017 Birmingham, UK;16th Global AnnualOncologistsMeeting, April 24-25, 2017 Dubai, UAE; Global Summit onOncology & Cancer, May 25-27, 2017 Osaka, Japan,; InternationalConference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE;9th InternationalCancer Biomarkers Conference, August 07-09, 2017 Osaka, Japan; 15th WorldCongress on Cancer Therapy(977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research andBiomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA;.

Track 6 : Cancer Stem Cells

Cancer Stem Cells areCancercells present in the tumors. They possess the normal stem cells characteristics i,e their ability to proliferate into different cell types by differentiation.Cancer stem cells are tumorigenic and develops tumors. They also lead to metastasis and relapse thus giving rise to the formation of new tumor cells.Hence there is a need to develop specific therapies targeted at Cancer stem cells to increase the chances of survival of Cancer patients.

Related Cancer Conferences|Cancer meetings|Oncology Conferences

Medical ExpoCongress on Cancer Drugsand Therapeutics, Sep 11-13, 2017 Paris, France; Global Expertsmeeting on OncologyCase Reports Aug 29-31, 2017 London, UK; 2ndCancer Diagnostics Conference& Expo, May 8-10, 2017 Barcelona, Spain; 9th InternationalConference Cancer BiomarkersAugust 23-24, 2017 Birmingham, UK;16th Global AnnualOncologistsMeeting, April 24-25, 2017 Dubai, UAE; Global Summit onOncology & Cancer, May 25-27, 2017 Osaka, Japan,; InternationalConference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE;9th InternationalCancer Biomarkers Conference, August 07-09, 2017 Osaka, Japan; 15th WorldCongress on Cancer Therapy(977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research andBiomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; InternationalConference on Epigenetics2017, November 13-15, 2017 Frankfurt, Germany; 19thWorld Cancer Conference, Nov 21-23, 2017 London, UK; 11th InternationalConference on Leukemiaand Hematologic Oncology December 04-05, 2017 Madrid, Spain;

Track 7 : Cancer Epigenetics

The study of epigenetic modifications to theCancercells genome is calledCancer Epigenetics, that does not bring a change in the nucleotide sequence. Risk expectation and prediction andCancerprevention, growth counteractive action are also promising and encouraging areas of Epigenetics.A high adequacy of demethylating agents were accounted for essentially in hematological malignancies in view of new conventions with low dose and long exposure, and their utilization is presently being striven for strong tumors.

During the cellstransformation to Cancerous cell, Epigenetic modifications are also mor important like genetic mutations. Their manipulation brings a great promising approach to for preventing , detecting and therapy of Cancer.

RelatedOncology Conferences|Cancer Conferences|Cancer meetings

19thWorld Cancer Conference, Nov 21-23, 2017 London, UK; 11th InternationalConference on Leukemiaand Hematologic Oncology December 04-05, 2017 Madrid, Spain; Medical ExpoCongress on Cancer Drugsand Therapeutics, Sep 11-13, 2017 Paris, France;16th Global AnnualOncologistsMeeting, April 24-25, 2017 Dubai, UAE; Global Summit onOncology & Cancer, May 25-27, 2017 Osaka, Japan,; InternationalConference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE;9th InternationalCancer Biomarkers Conference, August 07-09, 2017 Osaka, Japan; 15th WorldCongress on Cancer Therapy(977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research andBiomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; InternationalConference on Epigenetics2017, November 13-15, 2017 Frankfurt, Germany; Global Expertsmeeting on OncologyCase Reports Aug 29-31, 2017 London, UK; 2ndCancer Diagnostics Conference& Expo, May 8-10, 2017 Barcelona, Spain; 9th InternationalConference Cancer BiomarkersAugust 23-24, 2017 Birmingham, UK.

Track 8 : Epigenetics

Epigeneticsdeals with the study of heritable changes in gene , that does not include changes to the basic DNA arrangement an adjustment in phenotype without an adjustment in genotype which influences how cells read the genes.Epigeneticschange is a normal, natural and characteristic occurence yet can likewise be affected by a few factors including age, the environment/lifestyle, and illness state. Epigeneticsmodifications can show as normally as the way in which cells terminally separate to differentiate as liver cells, skin cells, etc.Alternately, epigenetic change can have all the more harming impacts that can bring illnesses, disease.

example :Cancer.

RelatedCancer Conferences|Cancer meetings|Oncology Conferences

16th Global AnnualOncologistsMeeting, April 24-25, 2017 Dubai, UAE; Global Summit onOncology & Cancer, May 25-27, 2017 Osaka, Japan,; InternationalConference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE;9th InternationalCancer Biomarkers Conference, August 07-09, 2017 Osaka, Japan; 15th WorldCongress on Cancer Therapy(977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research andBiomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; InternationalConference on Epigenetics2017, November 13-15, 2017 Frankfurt, Germany; 19thWorld Cancer Conference, Nov 21-23, 2017 London, UK; 11th InternationalConference on Leukemiaand Hematologic Oncology December 04-05, 2017 Madrid, Spain; Medical ExpoCongress on Cancer Drugsand Therapeutics, Sep 11-13, 2017 Paris, France; Global Expertsmeeting on OncologyCase Reports Aug 29-31, 2017 London, UK; 2ndCancer Diagnostics Conference& Expo, May 8-10, 2017 Barcelona, Spain; 9th InternationalConference Cancer BiomarkersAugust 23-24, 2017 Birmingham, UK.

Track 9 : Developmental and Nutritional Epigenetics

Epigeneticfactors are also called as epigenetic marks control many functions of cells in our bodies. From time to time,Epigeneticmarks cause certain genes to be turned on or off at various phases of the body's development and growth in a way that prompts to a disease onset

In this way, researchers and scientists have been able to find the thin line which is connecting the following diseases to Epigenetics

This track also deals with the modifications and changes that greatly affects the processes such as DNA methylation and histone modifications like embryonic development, aging, and carcinogenesis

Epigenetics plays a key role in wide range of diseases like type 2 Diabetes Mellitus, Obesity, inflammation, and neurocognitive disorders. Nutritional Epigenetics can be considered as an attractive tool to anticipate and prevent Cancer and pediatric developmental diseases

Related Cancer Conferences|Cancer meetings|Oncology Conferences

16th Global AnnualOncologistsMeeting, April 24-25, 2017 Dubai, UAE; InternationalConference on Epigenetics2017, November 13-15, 2017 Frankfurt, Germany; 19thWorld Cancer Conference, Nov 21-23, 2017 London, UK; 11th InternationalConference on Leukemiaand Hematologic Oncology December 04-05, 2017 Madrid, Spain; Medical ExpoCongress on Cancer Drugsand Therapeutics, Sep 11-13, 2017 Paris, France; Global Expertsmeeting on OncologyCase Reports Aug 29-31, 2017 London, UK; Global Summit onOncology & Cancer, May 25-27, 2017 Osaka, Japan,; InternationalConference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE;9th InternationalCancer Biomarkers Conference, August 07-09, 2017 Osaka, Japan; 15th WorldCongress on Cancer Therapy(977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research andBiomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; 2ndCancer Diagnostics Conference& Expo, May 8-10, 2017 Barcelona, Spain; 9th InternationalConference Cancer BiomarkersAugust 23-24, 2017 Birmingham, UK.

Track 10 : Transgenerational Epigenetic inheritance

Transgenerational epigenetic inheritance is the transmittance of information from one generation to another ,for example :from a parent to child.This affects the offspringstraits without changing the primary structure of DNA.In multicellular organisms the epigenetic inheritance has different mechansisms.

RelatedOncology Conferences|Cancer Conferences|Cancer meetings

16th Global AnnualOncologistsMeeting, April 24-25, 2017 Dubai, UAE; Global Summit onOncology & Cancer, May 25-27, 2017 Osaka, Japan,; InternationalConference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE;9th InternationalCancer Biomarkers Conference, August 07-09, 2017 Osaka, Japan; 15th WorldCongress on Cancer Therapy(977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research andBiomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; InternationalConference on Epigenetics2017, November 13-15, 2017 Frankfurt, Germany; 19thWorld Cancer Conference, Nov 21-23, 2017 London, UK; 11th InternationalConference on Leukemiaand Hematologic Oncology December 04-05, 2017 Madrid, Spain; Medical ExpoCongress on Cancer Drugsand Therapeutics, Sep 11-13, 2017 Paris, France; Global Expertsmeeting on OncologyCase Reports Aug 29-31, 2017 London, UK; 2ndCancer Diagnostics Conference& Expo, May 8-10, 2017 Barcelona, Spain; 9th InternationalConference Cancer BiomarkersAugust 23-24, 2017 Birmingham, UK.

Track 11 : Epigenetics - Neurodevelopmental and Neurodegenerative disease

Neurodegenerative disorders are among the major difficulties and among the most medical issues that should be withstanded by the world, particularly in light of expanding population age. They cause the degeneration and death of nerve cells as they form incurable conditions for treatment. According to a collaborative study of the WHO, the World Bank and the Harvard School of Public Health by 2020 neurodegenerative diseases,dementia will be the eighth cause of disease among developed regions.It is also estimated that they will occupy the worlds second leading cause of death by 2050, overtaking Cancer During embryogenesis and for differentiation of neural cells Epigenetic mechanisms are essential required. Thus, precise understanding of epigenetic mechanisms, including DNA methylation and histone modification, is important to elucidate the pathogenic pathways in neurodevelopmental disorders

Most common neurodegenerative diseases

RelatedCancer meetings|Oncology Conferences|Cancer Conferences

16th Global AnnualOncologistsMeeting, April 24-25, 2017 Dubai, UAE; Global Summit onOncology & Cancer, May 25-27, 2017 Osaka, Japan,; InternationalConference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE;9th InternationalCancer Biomarkers Conference, August 07-09, 2017 Osaka, Japan; 15th WorldCongress on Cancer Therapy(977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research andBiomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; InternationalConference on Epigenetics2017, November 13-15, 2017 Frankfurt, Germany; 19thWorld Cancer Conference, Nov 21-23, 2017 London, UK; 11th InternationalConference on Leukemiaand Hematologic Oncology December 04-05, 2017 Madrid, Spain; Medical ExpoCongress on Cancer Drugsand Therapeutics, Sep 11-13, 2017 Paris, France; Global Expertsmeeting on OncologyCase Reports Aug 29-31, 2017 London, UK; 2ndCancer Diagnostics Conference& Expo, May 8-10, 2017 Barcelona, Spain; 9th InternationalConference Cancer BiomarkersAugust 23-24, 2017 Birmingham, UK.

Track 12 : Epigenetic Diseases, Clinical Applications , Pharmacogenomics

This particular track deals with the onset of diseases and the required clinical applications and theraphy related to those diseases.

Pharmacogenomics is a combination of pharmacology and genomics.this branch of study is concerned with the influence of acquired and inherited genetic variation on drug response in patients by correlating gene expression or single-nucleotide polymorphisms with pharmacodynamics and pharmacokinetics. The genetic disorder occurrence is quite rare in polutaion.Some might be hereditary while the others are caused by mutations.

RelatedCancer meetings|Oncology Conferences|Cancer Conferences

16th Global AnnualOncologistsMeeting, April 24-25, 2017 Dubai, UAE; Global Summit onOncology & Cancer, May 25-27, 2017 Osaka, Japan,; InternationalConference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE;9th InternationalCancer Biomarkers Conference, August 07-09, 2017 Osaka, Japan; 15th WorldCongress on Cancer Therapy(977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research andBiomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; InternationalConference on Epigenetics2017, November 13-15, 2017 Frankfurt, Germany; 19thWorld Cancer Conference, Nov 21-23, 2017 London, UK; 11th InternationalConference on Leukemiaand Hematologic Oncology December 04-05, 2017 Madrid, Spain; Medical ExpoCongress on Cancer Drugsand Therapeutics, Sep 11-13, 2017 Paris, France; Global Expertsmeeting on OncologyCase Reports Aug 29-31, 2017 London, UK; 2ndCancer Diagnostics Conference& Expo, May 8-10, 2017 Barcelona, Spain; 9th InternationalConference Cancer BiomarkersAugust 23-24, 2017 Birmingham, UK.

Track 13 : Biomarkers and Bioinformatics Development in Epigenetics

Histones and DNA are chemically altered with epigenetic markers. They influence chromatin structure by changing the electrostatic nature of the chromatin or by altering the affinity of chromatin-binding proteins. DNA can be modified by methylation of cytosine bases

This track also deals with Bioinformatics role inEpigenetics.This branch is expected to make significant contributions to Epigenetics research. Studies in computational Epigeneticsinvolves the improvement and utilization of bioinformatics strategies for resolving the epigenetic questions, and in addition computational information examination and hypothetical displaying with regards to Epigenetics. This incorporates the effects of histone and DNA CpG island methylation.

Related Oncology Conferences|Cancer Conferences|Cancer meetings

15th WorldCongress on Cancer Therapy(977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research andBiomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; InternationalConference on Epigenetics2017, November 13-15, 2017 Frankfurt, Germany; 19thWorld Cancer Conference, Nov 21-23, 2017 London, UK; 11th InternationalConference on Leukemiaand Hematologic Oncology December 04-05, 2017 Madrid, Spain; Medical ExpoCongress on Cancer Drugsand Therapeutics, Sep 11-13, 2017 Paris, France; Global Expertsmeeting on OncologyCase Reports Aug 29-31, 2017 London, UK; 2ndCancer Diagnostics Conference& Expo, May 8-10, 2017 Barcelona, Spain; 9th InternationalConference Cancer BiomarkersAugust 23-24, 2017 Birmingham, UK; 16th Global AnnualOncologistsMeeting, April 24-25, 2017 Dubai, UAE; Global Summit onOncology & Cancer, May 25-27, 2017 Osaka, Japan,; InternationalConference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE;9th InternationalCancer Biomarkers Conference, August 07-09, 2017 Osaka, Japan.

Track 14 : Epigenomic Effects of Environmental Exposures

Environmental contaminants and toxicants are far reaching all through the world, and can incorporate different materials and chemicals, from by results of ignition to contaminationg trace metals and organic natural mixes utilized as a part of day by day life. Presentation to changing sums and sorts of these contaminants is connected to impacts on human wellbeing .The fields of natural wellbeing and toxicology have concentrated on bettering the comprehension of how these contaminants affect biological prcocesses so that their wellbeing effects can be lessened or anticipated.

Numerous diseases are brought about by various types of alterations among dfifferent genes. Some of these progressions are hereditary changes that are passed along in families while some are mutations that happen due various hazardous environmental factors .

RelatedOncology Conferences|Cancer Conferences|Cancer meetings

16th Global AnnualOncologistsMeeting, April 24-25, 2017 Dubai, UAE; Global Summit onOncology & Cancer, May 25-27, 2017 Osaka, Japan,; InternationalConference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE;9th InternationalCancer Biomarkers Conference, August 07-09, 2017 Osaka, Japan; 15th WorldCongress on Cancer Therapy(977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research andBiomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; InternationalConference on Epigenetics2017, November 13-15, 2017 Frankfurt, Germany; 19thWorld Cancer Conference, Nov 21-23, 2017 London, UK; 11th InternationalConference on Leukemiaand Hematologic Oncology December 04-05, 2017 Madrid, Spain; Medical ExpoCongress on Cancer Drugsand Therapeutics, Sep 11-13, 2017 Paris, France; Global Expertsmeeting on OncologyCase Reports Aug 29-31, 2017 London, UK; 2ndCancer Diagnostics Conference& Expo, May 8-10, 2017 Barcelona, Spain; 9th InternationalConference Cancer BiomarkersAugust 23-24, 2017 Birmingham, UK.

Track 15 : World Cancer Market

Oncology Market is increasing and will be paced on a wide scale.The world wide oncology market is expected to grow in upcoming years due to expanded industry R&D and high investments by multinational companies in the Cancer research.

Related Oncology Conferences|Cancer Conferences|Cancer meetings

15th WorldCongress on Cancer Therapy(977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research andBiomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; InternationalConference on Epigenetics2017, November 13-15, 2017 Frankfurt, Germany; 19thWorld Cancer Conference, Nov 21-23, 2017 London, UK; 11th InternationalConference on Leukemiaand Hematologic Oncology December 04-05, 2017 Madrid, Spain; Medical ExpoCongress on Cancer Drugsand Therapeutics, Sep 11-13, 2017 Paris, France; Global Expertsmeeting on OncologyCase Reports Aug 29-31, 2017 London, UK; 2ndCancer Diagnostics Conference& Expo, May 8-10, 2017 Barcelona, Spain; 9th InternationalConference Cancer BiomarkersAugust 23-24, 2017 Birmingham, UK; 16th Global AnnualOncologistsMeeting, April 24-25, 2017 Dubai, UAE; Global Summit onOncology & Cancer, May 25-27, 2017 Osaka, Japan,; InternationalConference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE;9th InternationalCancer Biomarkers Conference, August 07-09, 2017 Osaka, Japan.

Track 16 : Entreprenuers Investment Meet

A stage planned to associate Entrepreneurs, Proposers and the Investors around the world. It's expected to make and encourage the most streamlined and reasonable meeting place for drawing in individuals in worldwide business disdcussions, assessment and execution of promising business thoughts. A financial specialist might discover the most astounding potential venture openings all around, which give great quantifiable profit. For business visionaries, this would be a perfect place to discover appropriate speculators and accomplices to begin or potentially extend their business. Hence it is an impeccable place to associate Entrepreneurs, Business Owners, Early Stage Companies and Established Corporates with National or International Investors, Corporate Investors and Potential Business Partners.

Related|Oncology Conferences|Cancer Conferences|Cancer meetings

15th WorldCongress on Cancer Therapy(977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research andBiomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; InternationalConference on Epigenetics2017, November 13-15, 2017 Frankfurt, Germany; 19thWorld Cancer Conference, Nov 21-23, 2017 London, UK; 11th InternationalConference on Leukemiaand Hematologic Oncology December 04-05, 2017 Madrid, Spain; Medical ExpoCongress on Cancer Drugsand Therapeutics, Sep 11-13, 2017 Paris, France; Global Expertsmeeting on OncologyCase Reports Aug 29-31, 2017 London, UK; 2ndCancer Diagnostics Conference& Expo, May 8-10, 2017 Barcelona, Spain; 9th InternationalConference Cancer BiomarkersAugust 23-24, 2017 Birmingham, UK; 16th Global AnnualOncologistsMeeting, April 24-25, 2017 Dubai, UAE; Global Summit onOncology & Cancer, May 25-27, 2017 Osaka, Japan,; InternationalConference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE;9th InternationalCancer Biomarkers Conference, August 07-09, 2017 Osaka, Japan.

In the last few years, the market forCancerprofiling in Asia-Pacific region has seen huge development as a result of increasing incidence ofCancer, high demand for better healthcare services .

High prevalence ofCancer; expanding R&D subsidizing; expanding power of research exercises; expanding application for non-oncology illnesses; and developing organization between scholarly, biotechnology and pharmaceutical organizations are driving components of theCancergenomics and epigenetics market

CancerProfiling Market is divided by Application ,Diagnosis, Technique, Technology etc.

ByApplicationit consists of :

Diagnostic,

Personalized Medicine,

Research.

By Technique, it consists of :

Genomics,

Proteomics,

Metabolomics,

Epigenetics.

By Technology, it consists of :

It is estimated that the worldwide Cancer Profiling business sector is ready to achieve USD 61.87 Billion by 2021 from USD 25.82 Billion in 2016 according to the "Cancer Profiling Market".The following graph depicts the data pictorially.

Central point powering market development are increasing number of malignancy cases over the globe.

Components, for example, the expanding interest for personalized medicine and point-of-care diagnostic tests inCancerprofiling are required to offer an extensive variety of development open doors for players in the tumor profiling market. The personalized medicine segment to represent the biggest share of the worldwide cancer profiling application showcase in 2016.

Across the board continuous research in the part ofEpigeneticsin diseases and disorders in humans is fuelling the worldwide epigenetics drugs, diagnostic technologies and indicative advances.

In light of research territories, the market for Epigenetics is fragmented into developmental biology, drug discovery, oncology and other research areas. Other research areas include genome-wide regulatory mechanisms and research related to several metabolic and genetic diseases.

In light of geology, the market of Epigenetics is divided into North America, Europe, Asia, and the Rest of the World. North America is further sub-segmented into U.S. furthermore, Canada. In Asia, the degree for this present market's development is extending quickly. Asia represents about a large portion of all cancer cases analyzed around the world. This makes helpful conditions for the development of the Epigenetic medications and diagnostics advertise in Asian nations, particularly China, Japan, Australia, and South Korea, with Japan in theprevailing position.

As per the National Cancer Institute, malignancy is among the main sources of death around the world, for which according to a recent review, epigenetic inhibitors comprise of the attributes and capacities which have the potential in cancer prevention and control. This element has given an impulse to the examination directed on epigenetics in the oncology business

In the estimated period between 2015 to 2020 the Epigenetics market is relied upon to stay as the quantity of new participants in this market will continue ascending with the consistent appearance of new innovations combined with upgraded highlights.

See original here:
Epigenetics and Cancer 2017 | Epigenetics Conferences ...